%0 Journal Article
%T Contribution of Musculoskeletal Disorders to Chronic Lumbago in Parkinson¡¯s Disease
%A Makoto Shiraishi
%A Kensuke Shinohara
%A Masashi Akamatsu
%A Yasuhiro Hasegawa
%J Advances in Parkinson's Disease
%P 61-66
%@ 2169-9720
%D 2016
%I Scientific Research Publishing
%R 10.4236/apd.2016.53008
%X Purpose: To clarify the impact of bone metabolism disorder on lumbago in Parkinson¡¯s Disease
(PD). Methods: Data was retrospectively analyzed from 52 patients with PD in our outpatient clinic
for more than 1 year (mean age, 63 ¡À 4 years old; mean duration from onset, 6.3 ¡À 0.8 years).
Patients¡¯ characteristics, comorbid musculoskeletal disorders, serum bone metabolism biomarkers,
and bone mineral density were examined. Results: Twenty-one PD patients (40.2%) had
chronic lumbago. Severe comptocormia and scoliosis were the most common musculosketal disorders
in this group (47.6%) affected by lumbago, followed by osteoporosis (14.3%), compression
fracture (4.8%). There was no significant difference in the duration of PD, body mass index, frequency
of falls, bone mineral density, tartrate-resistant acid phosphatase-5b, osteocalcin, and
N-terminal telopeptide between PD patients with or without chronic lumbago. Multivaritae logistic
regression analysis identified the independent predictors of chroni lumbago in PD patients as
Hoen-Yahr stage (odds ration [OR] = 2.794, 95%CI 1.103 - 7.076), and elevated serum 1,25-OH<sub>2</sub> vitamin D level ([OR] = 0.92, 95%CI 0.86 - 98). Conclusion: Bone metabolism disorders are found
to be associated with chronic lumbago in PD patients.
%K Chronic Lumbago
%K Parkinson¡¯s Disease
%K Bone Mineral Metabolism
%K 1
%K 25-(OH)&lt
%K sub&gt
%K 2&lt
%K /sub&gt
%K -Vitamin D
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=69651